Aptorum Group Launches NativusWell®, a Novel Nutraceutical for Menopause, in China
NEW YORK & LONDON & PARIS–(BUSINESS WIRE)–Mar 2, 2023– Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group”), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics to tackling unmet medical needs, announces the exciting commercial launch of NativusWell ®, a new dietary supplement supporting women’s health throughout the Menopausal … Read more